Feb 29 |
Xenon Pharmaceuticals Inc (XENE) Reports Full Year and Q4 2023 Financial Results
|
Feb 29 |
Xenon Pharma GAAP EPS of -$0.64 beats by $0.12
|
Feb 29 |
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
|
Feb 29 |
Earnings Scheduled For February 29, 2024
|
Feb 28 |
Xenon Pharma Q4 2023 Earnings Preview
|
Feb 22 |
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
|
Feb 22 |
3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition
|
Feb 8 |
Xenon Pharmaceuticals: Analysts Still Positive Despite Recent Trial 'Setbacks'
|
Feb 7 |
Is Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Trading At A 39% Discount?
|
Jan 23 |
Here's Why You Should Add Xenon (XENE) to Your Portfolio Now
|